Conjugated Estrogens Injection and Vitrakvi (Larotrectinib Capsules)
Determining the interaction of Conjugated Estrogens Injection and Vitrakvi (Larotrectinib Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: conjugated estrogens
Brand name: Enjuvia, Premarin, Premarin Intravenous, Cenestin
Synonyms: Conjugated estrogens, Estrogens (Conjugated A/Synthetic)
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Vitrakvi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Conjugated Estrogens Injection-Vitrakvi (Larotrectinib Oral Solution)
- Conjugated Estrogens Injection-Vitrase
- Conjugated Estrogens Injection-Vitrase injection
- Conjugated Estrogens Injection-Vitravene
- Conjugated Estrogens Injection-Vitron-C
- Conjugated Estrogens Injection-Vituz
- Vitrakvi (Larotrectinib Capsules)-Conjugated estrogens Intravenous
- Vitrakvi (Larotrectinib Capsules)-Conjugated estrogens synthetic a
- Vitrakvi (Larotrectinib Capsules)-Conjugated estrogens synthetic b
- Vitrakvi (Larotrectinib Capsules)-Conjugated Estrogens Tablets
- Vitrakvi (Larotrectinib Capsules)-Conjugated estrogens vaginal
- Vitrakvi (Larotrectinib Capsules)-Conray